The Biden administration has relaunched its program sending free COVID-19 tests in the mail.{beacon} Health Care Health Care ...

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain up to four free COVID-19 tests through the U.S. Department of Health and ...

The announcement comes as the administration is trying to encourage people to get the updated COVID-19 vaccines from ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. In July, a High Court judge delivered a mixed ...

In July, a High Court judge delivered a mixed ruling in the long-running dispute that has pitted pharmaceutical giant Pfizer Inc and German drug manufacturer BioNTech SE, against Cambridge, ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...